益智藥市場－全球產業規模、佔有率、趨勢、機會和預測：按類型、產品類型、分銷管道、應用、地區和競爭格局分類，2021-2031年

全球益智藥市場預計將大幅成長，從 2025 年的 75.5 億美元成長到 2031 年的 165.8 億美元，複合年成長率為 14.01%。

人們對益智藥（包括天然或藥物成分，旨在增強創造力、記憶力和積極性等認知能力）的需求日益成長，這主要源於老年人希望延緩神經退化性疾病的進展，以及專業希望最大限度地提高思維效率。這種對大腦健康的濃厚興趣正在產生實際的市場效益。例如，美國植物委員會 (ABC) 報告稱，2024 年，主流零售通路中專注於認知健康的蘑菇補充劑銷量激增 114.5%。

然而，由於各國監管體系複雜多元，該產業面臨許多挑戰。天然化合物和合成化合物缺乏統一的分類標準，造成了市場准入壁壘，使全球分銷規劃更加複雜，並增加了遵循成本。嚴格的安全標準和標籤要求往往會延遲產品上市，阻礙製造商快速掌握新的國際市場機會。

市場促進因素

隨著玩家積極尋求能夠提升精神耐力、專注力和反應速度的補劑，益智藥在競技遊戲和電競領域的日益普及正在從根本上改變市場格局。這種人口結構的變化正推動認知增強劑從專業藥品走向主流消費品，尤其是一些含有α-GPC和L-酪胺酸等成分的即飲能量飲料。大型飲料公司正積極順應這一趨勢，透過收購遊戲品牌來鞏固市場佔有率。例如，Curig Dr Pepper在2025年10月發布的「2025會計年度第三季財報」中指出，其對生活方式能量飲料品牌Ghost的收購為其總銷售量和構成比成長貢獻了7.2個百分點，凸顯了該品類巨大的商業性影響力。

同時，人們對合成興奮劑的質疑以及對全面腦健康解決方案的偏好，導致植物來源和天然配方產品越來越受歡迎。這種轉變重新激發了人們對藥用蘑菇和傳統適應原的興趣。這些產品現在被作為提升思維清晰度和緩解壓力的優質輔助品進行銷售，製造商也推出了越來越多的「潔淨標示」產品，這些產品在提供神經保護功效的同時，避免了高咖啡因產品的副作用。 Vitamin Shoppe 於 2025 年 6 月發布的《2025 年健康與保健趨勢報告》顯示，用於認知支持的喜來芝銷量在第一季成長了 40%。此外，協和發酵工業株式會社 (Kyowa Hakko Kogyo) 於 2025 年 1 月發表的一篇報導指出，53% 的消費者對旨在促進大腦健康的飲品特別感興趣。

市場挑戰

全球益智藥市場受到國際司法管轄區複雜且差異巨大的法律規範的嚴重限制。製造商必須應對不一致的分類，某些化合物在一些國家核准為膳食補充劑，而在其他國家則被限制為藥品。這種監管碎片化迫使企業投入巨資進行配方改良並制定區域策略，從而耗費大量資金並延長產品上市時間。因此，這阻礙了統一的全球宣傳活動的實施，並減緩了產業的擴張。

鑑於消費者對認知支援產品的需求快速成長，這種監管摩擦尤其有害。根據責任營養委員會 (CRN) 2024 年的數據，作為益智藥類別關鍵成分的睡茄的使用率已達到膳食補充劑用戶的 8%，短短四年內成長了四倍。然而，當嚴格的合規標準和核准延遲限制了這些高需求成分的供應時，製造商不僅錯失了重要的市場機遇，還遭受了巨大的收入損失，並且由於供應無法滿足激增的消費者需求，阻礙了整體市場擴張。

市場趨勢

企業正擴大利用機器學習演算法和人工智慧來分析消費者的基因圖譜、生活方式數據和生物識別訊息，從而開發針對特定認知目標的客製化促智配方。這項創新實現了動態的營養補充方案，能夠根據用戶不斷變化的生理需求進行調整，標誌著「一刀切」式複合綜合維他命的時代正在發生重大轉變。 ADM 於 2025 年 8 月發布的報告《推動功能性零食市場的四大因素》顯示，市場對這種個人化解決方案的需求非常強勁，59% 的全球消費者希望獲得根據其獨特營養需求量身定做的產品。

除了飲料之外，功能性零食、口腔吸收片、口香糖和益智軟糖等替代給藥形式正變得越來越受歡迎，以提高遵守用藥和適口性。製造商正積極拓展產品線，推出這些產品，以應對“片劑疲勞”，並吸引那些更喜歡方便、糖果狀營養補充劑而非傳統膠囊的年輕消費者。這種多元化發展正獲得顯著的商業性動力。例如，NutraIngredients 2025 年 5 月發表的一篇報導《軟糖革命：蛋白質、美容和兒童營養領域的成長空間》報道稱，Sirio Pharma 僅在亞太地區 2024 年的銷售額就達到了約 4000 萬美元，凸顯了非片劑給藥系統的快速普及。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球益智藥市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（處方藥與非處方藥）
  • 依產品類型（天然系與合成）
  • 依分銷管道（線上與線下）分類
  • 依用途分類（改善記憶力、情緒與憂鬱症、注意力與專注力、延年益壽與老齡化、睡眠與恢復、焦慮、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美益智藥市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲益智藥市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區益智藥市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲益智藥市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲益智藥市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球益智藥市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Onnit
• Neurohacker Collective
• Mind Lab Pro
• Nootrogen
• HVMN
• Gaia Herbs
• NOW Foods
• Thorne
• GNC Holdings
• Natrol

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Nootropics Market is projected to experience substantial growth, expanding from USD 7.55 Billion in 2025 to USD 16.58 Billion by 2031, representing a compound annual growth rate of 14.01%. This rising demand for nootropics-defined as natural or pharmaceutical substances that improve cognitive abilities like creativity, memory, and motivation-is largely fueled by an aging demographic striving to slow neurodegenerative decline and professionals seeking to maximize mental efficiency. This keen interest in brain health is generating concrete market results; for example, the American Botanical Council reported that in 2024, sales of mushroom supplements focused on cognitive health surged by 114.5% within mainstream retail channels.

However, the industry encounters significant obstacles due to complicated and varying regulatory systems across different nations. The inconsistent categorization of natural versus synthetic compounds establishes major barriers to entry, thereby complicating global distribution plans and escalating compliance expenses. These rigorous safety standards and labeling mandates often postpone product releases, consequently hindering manufacturers' efforts to swiftly leverage emerging opportunities in new international regions.

Market Driver

The increasing use of nootropics within the competitive gaming and esports sectors is fundamentally transforming the market, as players actively seek supplements to improve mental endurance, focus, and reaction times. This demographic evolution has propelled cognitive enhancers from specialized pharmaceutical uses into mainstream consumer goods, notably via ready-to-drink energy beverages containing ingredients such as alpha-GPC and L-tyrosine. Major beverage corporations are aggressively pursuing this trend through acquisitions of gamer-focused brands to secure market share; for example, Keurig Dr Pepper noted in their October 2025 'Q3 2025 Results' that acquiring the lifestyle energy brand GHOST added 7.2 percentage points to their total volume/mix growth, underscoring the category's massive commercial influence.

Simultaneously, consumers are increasingly favoring plant-based and natural formulations due to skepticism regarding synthetic stimulants and a preference for holistic brain health solutions. This shift has renewed interest in medicinal mushrooms and traditional adaptogens, now marketed as premium aids for mental clarity and stress management, prompting manufacturers to release clean-label items offering neuroprotection without the side effects of high-caffeine products. The Vitamin Shoppe's 'Health and Wellness Trend Report 2025' from June 2025 highlighted a 40% Q1 increase in sales of shilajit for cognitive support, while a January 2025 article by Kyowa Hakko noted that 53% of consumers are specifically interested in beverages formulated for brain health.

Market Challenge

The Global Nootropics Market is severely constrained by complicated and divergent regulatory structures found across international jurisdictions. Manufacturers must navigate inconsistent classifications where a specific compound might be approved as a dietary supplement in one nation but restricted as a pharmaceutical in another. This regulatory fragmentation forces companies to invest in expensive reformulations and develop distinct regional strategies, which depletes financial resources and prolongs the time needed to bring products to market, ultimately preventing unified global campaigns and slowing industry expansion.

This regulatory friction is especially detrimental considering the rapid growth in consumer demand for cognitive support products. According to data from the Council for Responsible Nutrition in 2024, the use of ashwagandha-a key ingredient in the nootropic space-reached 8% among supplement users, representing a four-fold rise in just four years. However, when rigid compliance standards and approval delays restrict the supply of such high-demand ingredients, manufacturers fail to capitalize on critical market openings, leading to significant revenue loss and hindering broader market development as supply fails to meet the surging consumer appetite.

Market Trends

Companies are increasingly deploying machine learning algorithms and artificial intelligence to evaluate consumer genetic profiles, lifestyle data, and biometrics to create customized nootropic stacks that target specific cognitive objectives. This technological advancement enables the development of dynamic supplement regimens that adjust to a user's evolving physiological requirements, representing a significant shift away from static, one-size-fits-all multivitamins. There is substantial demand for such personalized solutions; as noted in ADM's 'Four Drivers Fueling the Functional Snacking Takeover' report from August 2025, 59% of global consumers have expressed a desire for products tailored to their unique nutritional needs.

Beyond beverages, there is a rising trend toward alternative delivery formats, such as functional snacks, oral strips, chewing gums, and nootropic-infused gummies, designed to enhance compliance and taste. Manufacturers are actively expanding their product lines with these options to combat "pill fatigue" and appeal to younger consumers who favor convenient, candy-like supplements over conventional capsules. This diversification is gaining significant commercial momentum; for instance, a May 2025 NutraIngredients article titled 'Gummy innovations: Protein, beauty, and kids nutrition offer room for growth' reported that Sirio Pharma achieved nearly USD 40 million in sales within the APAC region alone in 2024, highlighting the rapid adoption of non-pill delivery systems.

Key Market Players

• Onnit
• Neurohacker Collective
• Mind Lab Pro
• Nootrogen
• HVMN
• Gaia Herbs
• NOW Foods
• Thorne
• GNC Holdings
• Natrol

Report Scope

In this report, the Global Nootropics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nootropics Market, By Type

• Prescription v/s Over the Counter

Nootropics Market, By Product Type

• Natural v/s Synthetic

Nootropics Market, By Distribution Channel

• Online v/s Offline

Nootropics Market, By Application

• Memory Enhancement
• Mood & Depression
• Attention & Focus
• Longevity & Anti-aging
• Sleep & Recovery
• Anxiety
• Others

Nootropics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nootropics Market.

Available Customizations:

Global Nootropics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nootropics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Prescription v/s Over the Counter)
  • 5.2.2. By Product Type (Natural v/s Synthetic)
  • 5.2.3. By Distribution Channel (Online v/s Offline)
  • 5.2.4. By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Nootropics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nootropics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Distribution Channel
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Nootropics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Distribution Channel
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Nootropics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Distribution Channel
      • 6.3.3.2.4. By Application

7. Europe Nootropics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nootropics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Distribution Channel
      • 7.3.1.2.4. By Application
  • 7.3.2. France Nootropics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Distribution Channel
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Nootropics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Distribution Channel
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Nootropics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Distribution Channel
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Nootropics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Distribution Channel
      • 7.3.5.2.4. By Application

8. Asia Pacific Nootropics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Nootropics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Distribution Channel
      • 8.3.1.2.4. By Application
  • 8.3.2. India Nootropics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Distribution Channel
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Nootropics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Distribution Channel
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Nootropics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Distribution Channel
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Nootropics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Distribution Channel
      • 8.3.5.2.4. By Application

9. Middle East & Africa Nootropics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Nootropics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Distribution Channel
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Nootropics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Distribution Channel
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Nootropics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Distribution Channel
      • 9.3.3.2.4. By Application

10. South America Nootropics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Nootropics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Distribution Channel
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Nootropics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Distribution Channel
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Nootropics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Distribution Channel
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Nootropics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Onnit
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Neurohacker Collective
• 15.3. Mind Lab Pro
• 15.4. Nootrogen
• 15.5. HVMN
• 15.6. Gaia Herbs
• 15.7. NOW Foods
• 15.8. Thorne
• 15.9. GNC Holdings
• 15.10. Natrol

16. Strategic Recommendations

17. About Us & Disclaimer